Combination of lipid-lowering drugs: how to continue after the ACCORD trial?

Abstract

A discussionon the importance of agressive management of combined hyperlipidemia in diabetics and the role of fibrates after publication of the ACCORD study results.

Keywords

• Statins
• fibrates
• niacin
• ezetimibe
• combination therapy
• cardiovascular risk